Evidence map›Paper›PMID 26403799›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Near-IR Light-Mediated Cleavage of Antibody-Drug Conjugates Using Cyanine Photocages.

Roger R Nani, Alexander P Gorka, Tadanobu Nagaya, Hisataka Kobayashi, Martin J Schnermann

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Advancements in antibody-drug conjugates as cancer therapeutics.Journal of the National Cancer Center · 2025
    Review
  7. Article
  8. A hydrophobic photouncaging reaction to profile the lipid droplet interactome in tissues.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Review
  11. Light-Activated Anti-Vascular Combination Therapy against Choroidal Neovascularization.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roger R NaniChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD (USA).
Alexander P GorkaChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD (USA).
Tadanobu NagayaMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD (USA).
Hisataka KobayashiMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD (USA).
Martin J SchnermannChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD (USA). martin.schnermann@nih.gov.

Funding

Synthesis and evaluation of small-molecule imaging agentsZIABC011506 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNERMANN, MARTIN · 2013 to 2025
$12.1M
Near-IR Photorelease Chemistry: Discovery and ApplicationsZIABC011564 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNERMANN, MARTIN · 2014 to 2025
$9.5M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011506Intramural NIH HHS ZIA BC011564
6 · The paper itself

Abstract

Despite significant progress in the clinical application of antibody drug conjugates (ADCs), novel cleavage strategies that provide improved selectivity are still needed. Herein is reported the first approach that uses near-IR light to cleave a small molecule from a biomacromolecule, and its application to the problem of ADC linkage. The preparation of cyanine antibody conjugates, drug cleavage mediated by 690 nm light, and initial in vitro and in vivo evaluation is described. These studies provide the critical chemical underpinning from which to develop this near-IR light cleavable linker strategy.

Indexed as

AnimalsAntibodies, MonoclonalAntineoplastic Agents, PhytogenicCarbocyaninesCell Line, TumorCell SurvivalDose-Response Relationship, DrugDrug Screening Assays, AntitumorErbB ReceptorsHumansHymecromoneInfrared RaysMCF-7 CellsMiceNeoplasms, ExperimentalPanitumumab6,8-difluoro-4-methylumbelliferyl sulfateAntibodies, MonoclonalAntineoplastic Agents, PhytogenicCarbocyaninesErbB ReceptorsfosbretabulinHymecromonePanitumumabStilbenesantibodiesconjugationcyaninesdrug deliveryfluorescence

Identifiers

PMID26403799
PMCPMC4743669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.